The Ohio State University, through the Ohio State Innovation Foundation, has signed an exclusive world-wide licensing agreement with MedVax Technologies, Inc., for the licensing of groundbreaking cancer peptide vaccine technologies.
Mar 18, 2014
0
0
In a first-ever study, researchers at The Ohio State University Wexner Medical Center and College of Medicine examined the unintentional drug overdose mortality in years of life lost among adolescents and young people in ...
Jan 31, 2022
0
3
(Medical Xpress)—Determining whether a patient's lung cancer has spread to nearby lymph nodes is critical for identifying the most effective therapy, but it usually requires surgery. A new study suggests, however, that ...
Sep 24, 2013
0
0
A hormone-like substance produced by the body to promote inflammation can cause an aggressive form of leukemia when present at high levels, according to a new study by researchers at the Ohio State University Comprehensive ...
Nov 12, 2012
0
0
Blocking a protein in the heart that is produced under stressful conditions could be a strategy to prevent cardiac damage that results from chemotherapy, a new study suggests.
May 21, 2012
1
0
Physicians at The Ohio State University Wexner Medical Center are taking an innovative approach to improve care for patients receiving aortic valve replacements. They're working alongside biomedical engineers from Ohio State's ...
Mar 5, 2018
0
2
A new study led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) helps confirm that a molecule targeted ...
Dec 19, 2013
0
0
Tobacco-related diseases are the most preventable cause of death worldwide; smoking cessation leads to improvement in cancer treatment outcomes, as well as decreased recurrence. According to the American Cancer Society, in ...
Mar 13, 2015
0
10
New research shows that an enzyme that has long been considered relatively useless to the immune response instead has an important role in setting up immune cells to kill infection-causing bacteria.
Jun 11, 2012
0
0
A new study has identified a regulatory pathway in natural killer cells that inhibits their maturation and homing behavior. Natural killer cells are one of the body's first lines of defense against viruses and cancer. The ...
May 6, 2015
0
35
